Article ID Journal Published Year Pages File Type
2527445 Clinical Therapeutics 2012 18 Pages PDF
Abstract
These 10-week data from this patient population suggest a greater antihypertensive efficacy of the fixed-dose combination I300/A5 over I300 alone in lowering systolic blood pressure. Both treatments were well tolerated throughout the study. ClinicalTrials.gov identifier: NCT00957554.
Related Topics
Health Sciences Medicine and Dentistry Medicine and Dentistry (General)
Authors
, ,